Restart Life Sciences Statistics
Total Valuation
CSE:HEAL has a market cap or net worth of CAD 2.02 million. The enterprise value is 1.64 million.
Market Cap | 2.02M |
Enterprise Value | 1.64M |
Important Dates
The last earnings date was Tuesday, May 27, 2025.
Earnings Date | May 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:HEAL has 33.73 million shares outstanding. The number of shares has increased by 23.94% in one year.
Current Share Class | 33.73M |
Shares Outstanding | 33.73M |
Shares Change (YoY) | +23.94% |
Shares Change (QoQ) | +44.49% |
Owned by Insiders (%) | 9.98% |
Owned by Institutions (%) | 3.11% |
Float | 30.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 7.60 |
P/TBV Ratio | 7.60 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.64 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.74
Current Ratio | 2.74 |
Quick Ratio | 2.74 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -318.32% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -434.78% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.00% in the last 52 weeks. The beta is -0.42, so CSE:HEAL's price volatility has been lower than the market average.
Beta (5Y) | -0.42 |
52-Week Price Change | -70.00% |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 0.10 |
Relative Strength Index (RSI) | 45.47 |
Average Volume (20 Days) | 28,771 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.16M |
Pretax Income | -449,626 |
Net Income | -449,626 |
EBITDA | -1.15M |
EBIT | -1.16M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 388,310 in cash and n/a in debt, giving a net cash position of 388,310 or 0.01 per share.
Cash & Cash Equivalents | 388,310 |
Total Debt | n/a |
Net Cash | 388,310 |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 266,148 |
Book Value Per Share | 0.01 |
Working Capital | 257,534 |
Cash Flow
Operating Cash Flow | -260,754 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:HEAL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.94% |
Shareholder Yield | n/a |
Earnings Yield | -22.22% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.
Last Split Date | Jan 24, 2025 |
Split Type | Reverse |
Split Ratio | 0.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |